https://www.selleckchem.com/pr....oducts/ecc5004-azd50
The quality of evidence was moderate for these criteria except for cough (low quality of evidence). This review focuses on clinical elements necessary in a shared decision-making process. In practice, general practitioners will be able to use these data to discuss ACE inhibitor treatment with HFrEF patients. This study was registered in the PROSPERO registry under the reference number CRD42018096930. This review focuses on clinical elements necessary in a shared decision-making process. In practice, general practitioners will be
Like
Comment
Share
